14 Two therapeutic strategies currently exist to overcome the short half-life of incretin hormones and pharmacologically augment the incretin effect: 1) inject GLP-1 receptor agonists that are resistant to degradation by the DPP-4 enzyme and 2) orally administer DPP-4 inhibitors that delay the enzymatic degradation of naturally secreted incretin hormones ( Figure 2 )
Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1-renal Axis in man
Within scientific research, this peptide has received considerable attention in recent years because of its potential role in repair processes, tissue regeneration and support of various biological systems
Free From: Gluten, soy, dairy, GMOs
Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection